Upstream Bio, Inc. (UPB) has received a new Buy rating, initiated by TD Cowen analyst, Yaron Werber. Yaron Werber has given his Buy rating due ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported their initial public offerings.Shares in device maker CeriBell Inc.

Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.

The global upstream bioprocessing equipment market was valued at approximately US$ 7.75 billion in 2022 and is expected to ...

This page features the latest news about the Upstream Bio stock. OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares OrbiMed Advisors LLC, a prominent shareholder in Upstream Bio ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company ...

Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, visits the Nasdaq ...

Question: Auwe! Saturday was a shocking day at the Ala Wai Canal. Huge amounts of tree debris and garbage were floating ...

Q3 2024 Earnings Conference Call November 1, 2024 11:00 AM ETCompany ParticipantsPeter Shaw - VP, IRBrad Corson - ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...